Megace, #020264

Product Category

US FDA-Approved Medicine

Formulation

MEGESTROL ACETATE: 40 mg/mL Oral suspension

Delivery Method

Oral Suspension

Status

Discontinued

ANDA #

020264

Approval Date

19930910

Manufacturers